From: Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
Response
DP group
n = 103
S-1 group
n = 72
p value
CR
29 (28.2%)
18 (25.0%)
PR
47 (45.6%)
31 (43.1%)
SD
25 (24.3%)
21 (29.1%)
PD
2 (1.9%)
2 (2.8%)
ORR
76 (73.8%)
49 (68.1%)
0.497